No abstract available
Keywords:
JAK inhibitor; autoimmune myopathy; baricitinib; dermatomyositis; interferon; myositis; refractory; ruxolitinib.
MeSH terms
-
Adult
-
Dermatomyositis* / drug therapy
-
Humans
-
Janus Kinase Inhibitors* / therapeutic use
-
Pilot Projects